Charles River Laboratories | Értékesítés

Sales változás Dátum
Agilent USD 1.66B 30M 2023-12
Align Technology USD 956.73M 3.49M 2023-12
Bio-Rad Laboratories USD 681.18M 49.06M 2023-12
Bruker USD 854.5M 111.7M 2023-12
Cardinal Health USD 57.44B 2.68B 2023-12
Catalent USD 1.02B 42M 2023-12
Charles River Laboratories USD 1.01B 13.15M 2023-12
Cigna USD 51.11B 2.04B 2023-12
CVS Health USD 93.81B 4.05B 2023-12
Danaher USD 5.8B 605M 2024-03
Dentsply International USD 1.01B 65M 2023-12
Elevance Health 42.3B 154M 2024-03
Galapagos EUR 136.34M 29.08M 2023-09
Hologic USD 1.01B 67.8M 2023-12
Humana USD 29.33B 3.6B 2024-03
Illumina USD 1.12B 3M 2023-12
Incyte USD 1.01B 94.32M 2023-12
IQVIA Holdings USD 3.87B 132M 2023-12
Laboratory Of America USD 3.03B 23.5M 2023-12
Lonza CHF 3.64B 561M 2023-12
McKesson USD 80.9B 3.68B 2023-12
Merck EUR 5.22B 52M 2023-12
Mettler Toledo International USD 934.99M 7.47M 2023-12
Novartis USD 11.83B 54M 2024-03
Pfizer USD 14.25B 1.02B 2023-12
Quest Diagnostics USD 2.37B 82M 2024-03
Revvity USD 695.9M 25.16M 2023-12
Thermo Fisher Scientific USD 10.34B 546M 2024-03
United Therapeutics USD 614.7M 5.3M 2023-12
UnitedHealth 99.8B 5.37B 2024-03
Walgreens Boots Alliance USD 37.05B 345M 2023-12
Waters USD 819.47M 107.78M 2023-12
West Pharmaceutical Services USD 732M 15.4M 2023-12



Charles River Laboratories Értékesítés - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Apr 2024.